Analysis of Current Situation of FSMP Industry in 2021

Date: 2021-Aug-10 Source:IiMedia View: 480

Data shows that the market scale of foods for special medical purpose (FSMP) industry in China has increased from 2.59 billion Yuan in 2016 to 7.72 billion Yuan in 2020, which is about 3 times larger, and is expected to increase to 10.01 billion Yuan in 2021. In the future, driven by factors such as aging population, increasing downstream demand, and the construction and development of hospital nutrition departments, the market scale of FSMP will keep growing with an irreplaceable role in clinical nutritional support.

1. The Definition and Classification of FSMP

Foods for Special Medical Purpose (FSMP) refer to formula foods specially processed and prepared to meet the special needs of people with restricted eating, digestion and absorption disorders, metabolic disorders or specific disease status for nutrients or diet, including infant formula for special medical purpose for aged 0 months to 12 months and FSMP for aged over one year old. China implements strict registration approval management for FSMP.

image.png

image.png

2. Forecast Analysis of the Market Scale of the Global FSMP Industry in 2021

Data shows that the market scale of the Global FSMP increased from 58.3 billion Yuan to 73.9 billion Yuan from 2014 to 2018, and the growth rate was stable after 2015, both at about 6%. IiMedia Consulting analysts believe that with the intensification of the global population aging trend, the market scale of FSMP industry will further expand, and is expected to exceed 100 billion in recent years.

image.png

3. The market scale of Chinese FSMP industry keeps growing

Data shows that the market scale of Chinese FSMP industry keeps growing from 2016 to 2020. In particular, the outbreak of the epidemic in 2020 has made immune-enhancing foods and functional foods popular in the market, and the growth rate of the market scale of FSMP has increased significantly. IiMedia Consulting analysts believe that only 1.6% of malnourished patients in China are consuming FSMP, which is still a big gap compared with 65% in the United States. In the future, driven by factors such as aging population, increasing downstream demand, and the construction and development of hospital nutrition departments, the market scale of FSMP will keep growing with an irreplaceable role in clinical nutritional support.

image.png